Cart
sales@molnova.com
PF-06454589
CAS No. 1527473-30-8
PF-06454589( —— )
Catalog No. M20924 CAS No. 1527473-30-8
PF-06454589 is a potent inhibitor of LRRK2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 42 | Get Quote |
|
| 5MG | 68 | Get Quote |
|
| 10MG | 110 | Get Quote |
|
| 25MG | 205 | Get Quote |
|
| 50MG | 312 | Get Quote |
|
| 100MG | 484 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-06454589
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06454589 is a potent inhibitor of LRRK2.
-
DescriptionPF-06454589 is a potent inhibitor of LRRK2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetLRRK2
-
RecptorLRRK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1527473-30-8
-
Formula Weight284.31
-
Molecular FormulaC14H16N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 15.62 mg/mL (54.94 mM)
-
SMILESCn1cc(-c2c[nH]c3ncnc(N4CCOCC4)c23)cn1
-
Chemical Name4-[5-(1-methylpyrazol-4-yl)-7H-pyrrolo[23-d]pyrimidin-4-yl]morpholine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GSK2578215A
GSK2578215A is a highly potent, selective, BBB-permeable LRRK2 inhibitor with IC50 of 10.9 and 9.9 nM for wild-type LRRK2 and the G2019S mutant, respectively.
-
MLi-2
A potent, selective, orally available and brain-penetrant LRRK2 inhibitor with kinase IC50 of 0.76 nM, cellular IC50 of 1.4 nM (dephosphorylation of LRRK2 pSer935 LRRK2).
-
LRRK2-IN-7
LRRK2-IN-7 is a selective, CNS permeable and potent LRRK2 kinase inhibitor (IC50: 0.9 nM) for the study of Parkinson's disease.
